Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Rudnick

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Forensic Sciences|January 1, 1984
The identification of a murder victim using a comparison of the postmortem and antemortem recordsS A Rudnick
Experimental Hematology|September 1, 1991
Erythropoietin: evolving clinical applicationsR I Abels, S A Rudnick
Journal of the National Cancer Institute|June 1, 1980
An analysis of the reporting of results in lung cancer drug trialsS A Rudnick, A R Feinstein
Controlled Clinical Trials|June 1, 1983
Use of cost-effectiveness analysis in planning cancer chemoprophylaxis trialsH A Guess, S A Rudnick
Contributions to Nephrology|January 1, 1991
The role of recombinant human erythropoietin in the management of anemia associated with acquired immunodeficiency syndromeM B Garnick, R Abels, S A Rudnick
Archives of Pathology & Laboratory Medicine|July 1, 1980
Breast carcinoma metastatic to meningiomaE Nunnery, L B Kahn, S A Rudnick
North Carolina Medical Journal|January 1, 1981
Childhood Burkitt-type lymphoma at the North Carolina Memorial HospitalD Gaddy, S A Rudnick, C McMillan, et al.
Lancet (London, England)|September 17, 1988
Subcutaneous erythropoietinK J Boughton, R I Abels, S A Rudnick
Cancer Research|May 1, 1982
Methotrexate cytotoxicity for L5178Y/Asn- lymphoblasts: relationship of dose and duration of exposure to tumor cell viabilityD A Keefe, R L Capizzi, S A Rudnick
Cancer Treatment Reports|March 1, 1982
Randomized phase II comparison of methotrexate with or without L-asparaginase in non-small cell cancer of the lungS A Rudnick, E Neijstrom, R L Capizzi, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Forensic Sciences|January 1, 1984
The identification of a murder victim using a comparison of the postmortem and antemortem recordsS A Rudnick
Experimental Hematology|September 1, 1991
Erythropoietin: evolving clinical applicationsR I Abels, S A Rudnick
Journal of the National Cancer Institute|June 1, 1980
An analysis of the reporting of results in lung cancer drug trialsS A Rudnick, A R Feinstein
Controlled Clinical Trials|June 1, 1983
Use of cost-effectiveness analysis in planning cancer chemoprophylaxis trialsH A Guess, S A Rudnick
Contributions to Nephrology|January 1, 1991
The role of recombinant human erythropoietin in the management of anemia associated with acquired immunodeficiency syndromeM B Garnick, R Abels, S A Rudnick
Archives of Pathology & Laboratory Medicine|July 1, 1980
Breast carcinoma metastatic to meningiomaE Nunnery, L B Kahn, S A Rudnick
North Carolina Medical Journal|January 1, 1981
Childhood Burkitt-type lymphoma at the North Carolina Memorial HospitalD Gaddy, S A Rudnick, C McMillan, et al.
Lancet (London, England)|September 17, 1988
Subcutaneous erythropoietinK J Boughton, R I Abels, S A Rudnick
Cancer Research|May 1, 1982
Methotrexate cytotoxicity for L5178Y/Asn- lymphoblasts: relationship of dose and duration of exposure to tumor cell viabilityD A Keefe, R L Capizzi, S A Rudnick
Cancer Treatment Reports|March 1, 1982
Randomized phase II comparison of methotrexate with or without L-asparaginase in non-small cell cancer of the lungS A Rudnick, E Neijstrom, R L Capizzi, et al.
Pageof 3